Bruce Kovner, Director, 10% Owner at SYNTA PHARMACEUTICALS CORP (SNTA), bought 300,000 shares at $3.08 ($924K) on 2014-09-30, disclosed to the SEC on 2014-10-01.
Open-market purchase of $924k SNTA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SBBP | BUY | 2018-12-21 | $1.3M | — | Filing → |
| SBBP | BUY | 2018-08-09 | $3.6M | — | Filing → |
| SBBP | BUY | 2018-07-27 | $2.6M | — | Filing → |